Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 3
2011 2
2012 1
2013 3
2014 6
2015 1
2016 5
2017 9
2018 5
2019 7
2020 18
2021 15
2022 15
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Lixisenatide in Early Parkinson's Disease.
Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: fabbri m. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.
Amantadine use in the French prospective NS-Park cohort.
Fabbri M, Rousseau V, Corvol JC, Sommet A, Tubach F, De Rycke Y, Bertille N, Selvarasa Y, Carvalho S, Chaigneau V, Brefel-Courbon C, Ory-Magne F, Tessier S, Tir M, Bereau M, Meissner WG, Thiriez C, Marques A, Remy P, Schneider V, Moro E, Defebvre L, Houeto JL, Prange S, Eusebio A, Geny C, Frismand S, Damier P, Reuther CG, Castelnovo G, Benatru I, De Maindreville AD, Drapier S, Maltête D, Lagha-Boukbiza O, Rascol O; French N. S.-Park network. Fabbri M, et al. J Neural Transm (Vienna). 2024 Apr 5. doi: 10.1007/s00702-024-02772-4. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 38578434
Patient-perceived progression in multiple system atrophy: natural history of quality of life.
Saulnier T, Fabbri M, Le Goff M, Helmer C, Pavy-Le Traon A, Meissner WG, Rascol O, Proust-Lima C, Foubert-Samier A. Saulnier T, et al. Among authors: fabbri m. J Neurol Neurosurg Psychiatry. 2024 Mar 7:jnnp-2023-332733. doi: 10.1136/jnnp-2023-332733. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38453477 Free article.
Recent Advances in Clinical Trials in Multiple System Atrophy.
Bendetowicz D, Fabbri M, Sirna F, Fernagut PO, Foubert-Samier A, Saulnier T, Le Traon AP, Proust-Lima C, Rascol O, Meissner WG. Bendetowicz D, et al. Among authors: fabbri m. Curr Neurol Neurosci Rep. 2024 Apr;24(4):95-112. doi: 10.1007/s11910-024-01335-0. Epub 2024 Feb 28. Curr Neurol Neurosci Rep. 2024. PMID: 38416311 Review.
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Barbosa RP, Moreau C, Rolland AS, Rascol O, Brefel-Courbon C, Ory-Magne F, Bastos P, de Barros A, Hainque E, Rouaud T, Marques A, Eusebio A, Benatru I, Drapier S, Guehl D, Maltete D, Tranchant C, Wirth T, Giordana C, Tir M, Thobois S, Hopes L, Hubsch C, Jarraya B, Corvol JC, Bereau M, Devos D, Fabbri M; PREDISTIM Group. Barbosa RP, et al. Among authors: fabbri m. J Neurol. 2024 May;271(5):2582-2595. doi: 10.1007/s00415-023-12162-7. Epub 2024 Feb 9. J Neurol. 2024. PMID: 38334813
Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease: An analysis of survival and disability milestones.
Barbosa R, Guedes LC, Cattoni MB, Lobo PP, Caldas AC, Fabbri M, Bastos P, Valadas A, Carvalho H, Albuquerque L, Reimão S, Ferreira AG, Ferreira JJ, Rosa MM, Coelho M. Barbosa R, et al. Among authors: fabbri m. Parkinsonism Relat Disord. 2024 Jan;118:105921. doi: 10.1016/j.parkreldis.2023.105921. Epub 2023 Nov 11. Parkinsonism Relat Disord. 2024. PMID: 37976978
Overview on wearable sensors for the management of Parkinson's disease.
Moreau C, Rouaud T, Grabli D, Benatru I, Remy P, Marques AR, Drapier S, Mariani LL, Roze E, Devos D, Dupont G, Bereau M, Fabbri M. Moreau C, et al. Among authors: fabbri m. NPJ Parkinsons Dis. 2023 Nov 2;9(1):153. doi: 10.1038/s41531-023-00585-y. NPJ Parkinsons Dis. 2023. PMID: 37919332 Free PMC article. Review.
Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients.
Camgrand E, Christine BC, Harroch E, Chouquet C, Barthelemy C, Ory-Magne F, Leung C, Barbosa RP, Rascol O, Fabbri M. Camgrand E, et al. Among authors: fabbri m. Parkinsonism Relat Disord. 2023 Nov;116:105859. doi: 10.1016/j.parkreldis.2023.105859. Epub 2023 Sep 28. Parkinsonism Relat Disord. 2023. PMID: 37788512 No abstract available.
98 results